{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:05:13Z","timestamp":1773936313346,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071668"],"award-info":[{"award-number":["82071668"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000666"],"award-info":[{"award-number":["82000666"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016692","name":"Key Research and Development Program of Ningxia","doi-asserted-by":"publisher","award":["2024BEG02021"],"award-info":[{"award-number":["2024BEG02021"]}],"id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2019RU023"],"award-info":[{"award-number":["2019RU023"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7212114"],"award-info":[{"award-number":["7212114"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7254431"],"award-info":[{"award-number":["7254431"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["2024AAC02081"],"award-info":[{"award-number":["2024AAC02081"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.placenta.2025.12.010","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T07:15:49Z","timestamp":1766646949000},"page":"153-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Complement factor H-point mutation promotes the development of preeclampsia-like phenotype with multiparity in mice"],"prefix":"10.1016","volume":"174","author":[{"given":"Fei-fei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-dong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.placenta.2025.12.010_bib1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/AOG.0000000000002114","article-title":"Pregnancy-related mortality in the United States, 2011-2013","volume":"130","author":"Creanga","year":"2017","journal-title":"Obstet. Gynecol."},{"issue":"2s","key":"10.1016\/j.placenta.2025.12.010_bib2","doi-asserted-by":"crossref","first-page":"S1059","DOI":"10.1016\/j.ajog.2020.09.038","article-title":"Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"226","author":"Burwick","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.placenta.2025.12.010_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/aji.12162","article-title":"Maternal and fetal alternative complement pathway activation in early severe preeclampsia","volume":"71","author":"Hoffman","year":"2014","journal-title":"American journal of reproductive immunology (New York, NY : 1989)"},{"key":"10.1016\/j.placenta.2025.12.010_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jri.2014.12.002","article-title":"Complement factor B activation in patients with preeclampsia","volume":"109","author":"Velickovic","year":"2015","journal-title":"J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.placenta.2025.12.010_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jri.2012.11.006","article-title":"Elevated complement factor C5a in maternal and umbilical cord plasma in preeclampsia","volume":"97","author":"Denny","year":"2013","journal-title":"J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.placenta.2025.12.010_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/aji.12541","article-title":"Expression of the complement system's activation factors in plasma of patients with early\/late-onset severe pre-eclampsia","volume":"76","author":"He","year":"2016","journal-title":"American journal of reproductive immunology (New York, NY : 1989)"},{"issue":"4","key":"10.1016\/j.placenta.2025.12.010_bib7","first-page":"551","article-title":"Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid","volume":"73","author":"Haeger","year":"1989","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.placenta.2025.12.010_bib8","first-page":"698","article-title":"Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"76","author":"Haeger","year":"1990","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.placenta.2025.12.010_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/aji.12586","article-title":"Complement component C1q as potential diagnostic but not predictive marker of preeclampsia","volume":"76","author":"Agostinis","year":"2016","journal-title":"American journal of reproductive immunology (New York, NY : 1989)"},{"issue":"6","key":"10.1016\/j.placenta.2025.12.010_bib10","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/AOG.0000000000002980","article-title":"Terminal complement activation in Preeclampsia","volume":"132","author":"Burwick","year":"2018","journal-title":"Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.placenta.2025.12.010_bib11","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.placenta.2008.07.008","article-title":"The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro","volume":"29","author":"Rampersad","year":"2008","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.placenta.2025.12.010_bib12","article-title":"Upregulation and release of soluble fms-like tyrosine kinase receptor 1 mediated by complement activation in human syncytiotrophoblast cells","volume":"80","author":"Banadakoppa","year":"2018","journal-title":"American journal of reproductive immunology (New York, NY : 1989)"},{"issue":"3","key":"10.1016\/j.placenta.2025.12.010_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/10641955.2019.1640725","article-title":"Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia","volume":"38","author":"Yonekura","year":"2019","journal-title":"Hypertens. Pregnancy"},{"issue":"5","key":"10.1016\/j.placenta.2025.12.010_bib14","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/HYPERTENSIONAHA.112.194324","article-title":"Preeclampsia is characterized by placental complement dysregulation","volume":"60","author":"Buurma","year":"2012","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"4","key":"10.1016\/j.placenta.2025.12.010_bib15","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2007.10.793","article-title":"Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia","volume":"198","author":"Lynch","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.placenta.2025.12.010_bib16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1471-0528.2009.02473.x","article-title":"The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia","volume":"117","author":"Lynch","year":"2010","journal-title":"BJOG An Int. J. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.placenta.2025.12.010_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/AOG.0b013e3181fc3afa","article-title":"Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes","volume":"117","author":"Lynch","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2025.12.010_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molimm.2020.03.021","article-title":"Dysregulation of complement system during pregnancy in patients with preeclampsia: a prospective study","volume":"122","author":"He","year":"2020","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.placenta.2025.12.010_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/AOG.0000000000001340","article-title":"From gestational hypertension and Preeclampsia to atypical hemolytic uremic syndrome","volume":"127","author":"Tsai","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.placenta.2025.12.010_bib20","first-page":"239","volume":"17","author":"Richani","year":"2005","journal-title":"The Intern. Soc. Perinatal Obstet"},{"issue":"6","key":"10.1016\/j.placenta.2025.12.010_bib21","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/eji.1830220635","article-title":"Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55)","volume":"22","author":"Holmes","year":"1992","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.placenta.2025.12.010_bib22","article-title":"Normal range of complement components during pregnancy: a prospective study","volume":"83","author":"He","year":"2020","journal-title":"American journal of reproductive immunology (New York, NY : 1989)"},{"issue":"2","key":"10.1016\/j.placenta.2025.12.010_bib23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","article-title":"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome","volume":"111","author":"Fang","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.placenta.2025.12.010_bib24","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1182\/blood-2008-03-144691","article-title":"Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"112","author":"Fakhouri","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.placenta.2025.12.010_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med."},{"issue":"11","key":"10.1016\/j.placenta.2025.12.010_bib26","first-page":"2322","volume":"25","author":"Crovetto","year":"2012","journal-title":"The Intern. Soc. Perinatal Obstet"},{"issue":"2","key":"10.1016\/j.placenta.2025.12.010_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117840","article-title":"Genetic analysis of membrane cofactor protein (CD46) of the complement system in women with and without preeclamptic pregnancies","volume":"10","author":"Lokki","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.placenta.2025.12.010_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99128","article-title":"Germline mutations in the alternative pathway of complement predispose to HELLP syndrome","volume":"3","author":"Vaught","year":"2018","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.placenta.2025.12.010_bib29","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1371\/journal.pgen.0030041","article-title":"Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome","volume":"3","author":"Zipfel","year":"2007","journal-title":"PLoS Genet."},{"issue":"12","key":"10.1016\/j.placenta.2025.12.010_bib30","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood-2009-02-205641","article-title":"Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation","volume":"114","author":"Heinen","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.placenta.2025.12.010_bib31","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/HYPERTENSIONAHA.119.14598","article-title":"Animal models of Preeclampsia: causes, consequences, and interventions","volume":"75","author":"Gatford","year":"2020","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"13","key":"10.1016\/j.placenta.2025.12.010_bib32","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood.2019001040","article-title":"Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy","volume":"134","author":"Zheng","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.placenta.2025.12.010_bib33","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood-2016-07-728253","article-title":"Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation","volume":"129","author":"Ueda","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.placenta.2025.12.010_bib34","article-title":"Fenofibrate improved interstitial fibrosis of renal allograft through inhibited epithelial-mesenchymal transition induced by oxidative stress","volume":"2019","author":"Wang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.placenta.2025.12.010_bib35","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/biolre\/ioy025","article-title":"The intervention effect of aspirin on a lipopolysaccharide-induced preeclampsia-like mouse model by inhibiting the nuclear factor-\u03baB pathway","volume":"99","author":"Li","year":"2018","journal-title":"Biol. Reprod."},{"issue":"7","key":"10.1016\/j.placenta.2025.12.010_bib36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.placenta.2025.12.010_bib37","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.placenta.2025.12.010_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncpneph0018","article-title":"Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management?","volume":"1","author":"Noris","year":"2005","journal-title":"Nat. Clin. Pract. Nephrol."},{"issue":"11","key":"10.1016\/j.placenta.2025.12.010_bib39","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.imbio.2016.06.002","article-title":"Role of collectins and complement protein C1q in pregnancy and parturition","volume":"221","author":"Madhukaran","year":"2016","journal-title":"Immunobiology"},{"issue":"7\u20138","key":"10.1016\/j.placenta.2025.12.010_bib40","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.molimm.2010.01.021","article-title":"Activation of the complement system in normal pregnancy and preeclampsia","volume":"47","author":"Derzsy","year":"2010","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.placenta.2025.12.010_bib41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/aji.12349","article-title":"Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia","volume":"73","author":"Guseh","year":"2015","journal-title":"American journal of reproductive immunology (New York, NY : 1989)"},{"issue":"1 Pt 2","key":"10.1016\/j.placenta.2025.12.010_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/01.HYP.35.1.367","article-title":"Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat","volume":"35","author":"Crews","year":"2000","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"4","key":"10.1016\/j.placenta.2025.12.010_bib43","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.HYP.37.4.1191","article-title":"Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide","volume":"37","author":"Alexander","year":"2001","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"10","key":"10.1016\/j.placenta.2025.12.010_bib44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.ki.5002175","article-title":"Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1","volume":"71","author":"Makris","year":"2007","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.placenta.2025.12.010_bib45","doi-asserted-by":"crossref","first-page":"9565","DOI":"10.1038\/s41598-019-45959-6","article-title":"Characterisation of the selective reduced uteroplacental perfusion (sRUPP) model of Preeclampsia","volume":"9","author":"Morton","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.placenta.2025.12.010_bib46","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/HYPERTENSIONAHA.113.01449","article-title":"Gestational hypoxia induces preeclampsia-like symptoms via heightened endothelin-1 signaling in pregnant rats","volume":"62","author":"Zhou","year":"2013","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"4","key":"10.1016\/j.placenta.2025.12.010_bib47","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1159\/000487727","article-title":"Chronic prenatal hypoxia down-regulated BK channel \u03921 subunits in mesenteric artery smooth muscle cells of the offspring","volume":"45","author":"Liu","year":"2018","journal-title":"Cell. Physiol. Biochem. : Int, J. Exp. Cell. Phys. Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.placenta.2025.12.010_bib48","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/HYPERTENSIONAHA.118.11363","article-title":"Maternal allopurinol prevents cardiac dysfunction in adult Male offspring programmed by chronic hypoxia during pregnancy","volume":"72","author":"Niu","year":"2018","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"5","key":"10.1016\/j.placenta.2025.12.010_bib49","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/rep.1.00260","article-title":"Selenium deficiency as a model of experimental pre-eclampsia in rats","volume":"128","author":"Vanderlelie","year":"2004","journal-title":"Reproduction (Cambridge, England)"},{"issue":"2","key":"10.1016\/j.placenta.2025.12.010_bib50","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/HYPERTENSIONAHA.109.141473","article-title":"Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats","volume":"55","author":"Murphy","year":"2010","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"5","key":"10.1016\/j.placenta.2025.12.010_bib51","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/0002-9378(93)90299-X","article-title":"Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia","volume":"169","author":"Yallampalli","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.placenta.2025.12.010_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mob.2002.119178","article-title":"Growth and fertility rates in the offspring of pregnant rats treated with L-omega nitro-L-arginine methyl ester (L-NAME), a nitric oxide inhibitor","volume":"186","author":"Witlin","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.placenta.2025.12.010_bib53","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.placenta.2004.07.009","article-title":"Placental dysfunction in Suramin-treated rats--a new model for pre-eclampsia","volume":"26","author":"Nash","year":"2005","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.placenta.2025.12.010_bib54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/eji.200324469","article-title":"Introducing a mouse model for pre-eclampsia: adoptive transfer of activated Th1 cells leads to pre-eclampsia-like symptoms exclusively in pregnant mice","volume":"34","author":"Zenclussen","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.placenta.2025.12.010_bib55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1084\/jem.20130295","article-title":"Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia","volume":"211","author":"Cotechini","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.placenta.2025.12.010_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.placenta.2016.03.002","article-title":"Curcumin improves LPS-induced preeclampsia-like phenotype in rat by inhibiting the TLR4 signaling pathway","volume":"41","author":"Gong","year":"2016","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.placenta.2025.12.010_bib57","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14038","article-title":"Chronic infusion of interleukin-17 promotes hypertension, activation of cytolytic natural killer cells, and vascular dysfunction in pregnant rats","volume":"7","author":"Travis","year":"2019","journal-title":"Physiol. Rep."},{"issue":"4","key":"10.1016\/j.placenta.2025.12.010_bib58","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/HYPERTENSIONAHA.109.137935","article-title":"Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1","volume":"54","author":"LaMarca","year":"2009","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"6","key":"10.1016\/j.placenta.2025.12.010_bib59","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/HJH.0000000000001695","article-title":"Preeclampsia induced by STOX1 overexpression in mice induces intrauterine growth restriction, abnormal ultrasonography and BOLD MRI signatures","volume":"36","author":"Collinot","year":"2018","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.placenta.2025.12.010_bib60","doi-asserted-by":"crossref","first-page":"396.e1","DOI":"10.1016\/j.ajog.2006.12.024","article-title":"The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice","volume":"196","author":"Lu","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.placenta.2025.12.010_bib61","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/HYPERTENSIONAHA.109.134668","article-title":"Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice","volume":"54","author":"Suzuki","year":"2009","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.placenta.2025.12.010_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013663","article-title":"A new mouse model to explore therapies for preeclampsia","volume":"5","author":"Ahmed","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.placenta.2025.12.010_bib63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat. Rev. Nephrol."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425007702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425007702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:10:41Z","timestamp":1773929441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400425007702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":63,"alternative-id":["S0143400425007702"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2025.12.010","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement factor H-point mutation promotes the development of preeclampsia-like phenotype with multiparity in mice","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2025.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}